16th GAVI BOARD MEETING
Paris, France, 19-20 July, 2005
Summary Report

12. Yellow fever stockpile evaluation

• The presentation would have benefited from a clearer analysis of costs and benefits. For example it may be that a longer-term 5 year tender could produce significantly reduced costs when compared to 1 year tender, but there was not enough information on this to make an evidence-based decision.
• Effective strategic decision making can not be achieved on an emergency funding basis. Rather, the Board must be able to assess the merit of a given investment and its added value as compared to other funding priorities.

DECISIONS

The Board:

12.1 Approved a one-year extension of the six million dose yellow fever stockpile considering the urgent need to issue a tender to ensure no interruption in vaccine supply.

12.2 Requested a comprehensive investment case be prepared and submitted to the Board before it could consider a longer-term investment in the stockpile.